Asia Pacific In Vitro Diagnostics (IVD) Market Analysis, By Product (Reagents, Instruments, And Services), By Technology (Immunoassays, Clinical Chemistry, Hematology, Molecular Diagnosis, Microbiology And Coagulation), By Application (Infectious Diseases, Oncology, Cardiology, Nephrology, Autoimmune Diseases, HIV, Drug Testing), By End-Use (Hospitals, Laboratories, Homecare Diagnostics, Research Institutes) And Segment Forecasts To 2024
The Asia Pacific In Vitro Diagnostics (IVD) market is expected to reach USD 33.4 billion by 2024, according to a new report by Grand View Research, Inc. The Asia Pacific IVD market is anticipated to witness lucrative growth during the period 2016 to 2024. The growth of the market is attributed to an increase in the number of infectious and chronic diseases as well as technological advancements in the field of in vitro diagnostics.
Additionally, factors such as an increase in per capita income, the swiftly growing economies of India and China, increase in gross domestic product, and the rising disposable income are expected to be opportunistic for the industry growth. However, the presence of stringent regulatory policies, inadequate budget, and reimbursement issues are likely to hinder the growth of the market in the near future.
The Asia Pacific IVD market is segmented into technology, application, end-user, and region. Based on the product type, the industry is categorized into reagents, instruments, and services. The reagents market is estimated to hold the largest revenue share owing to the extensive use of reagents in diagnostics.
The molecular diagnostics segment is anticipated to be the fastest growing segment. On the basis of application, the market is categorized into infectious diseases, oncology, cardiology, nephrology, autoimmune diseases, HIV and drug testing. The large market share of this segment is attributed to the rising prevalence of infectious diseases. End-user applications include hospitals, laboratories, homecare diagnostics, and research institutes among others.
Further key findings from the study suggest:
In terms of growth, the Chinese in vitro diagnostics industry is anticipated to witness rapid growth in the next few years. Factors attributing to the growth of this industry in China include the increasing healthcare expenditure, GDP growth, rising population base, and more favorable health insurance coverage.
Infectious diseases segment was identified as the largest revenue generating category in the application segment and is estimated to maintain its position due to the continual rise in the number of diseases estimated for the next few years.
The in vitro diagnostics industry comprises several local as well as global players. Some of the major players in this industry include Danaher Corporation, Affymetrix, Inc., Abbott Laboratories, Alere, Inc., Roche Diagnostics among others.
In order to gain a major share in the industry, the companies adopted both organic as well as inorganic growth strategies. The key strategies undertaken by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. For instance,in October 2015, Cepheid announced the launch of its newly developed, FDA approved test ‘Xpert TV’, an in-vitro diagnostic test for the accurate identification of Trichomoniasis in female patients.
Additionally, factors such as an increase in per capita income, the swiftly growing economies of India and China, increase in gross domestic product, and the rising disposable income are expected to be opportunistic for the industry growth. However, the presence of stringent regulatory policies, inadequate budget, and reimbursement issues are likely to hinder the growth of the market in the near future.
The Asia Pacific IVD market is segmented into technology, application, end-user, and region. Based on the product type, the industry is categorized into reagents, instruments, and services. The reagents market is estimated to hold the largest revenue share owing to the extensive use of reagents in diagnostics.
The molecular diagnostics segment is anticipated to be the fastest growing segment. On the basis of application, the market is categorized into infectious diseases, oncology, cardiology, nephrology, autoimmune diseases, HIV and drug testing. The large market share of this segment is attributed to the rising prevalence of infectious diseases. End-user applications include hospitals, laboratories, homecare diagnostics, and research institutes among others.
Further key findings from the study suggest:
In terms of growth, the Chinese in vitro diagnostics industry is anticipated to witness rapid growth in the next few years. Factors attributing to the growth of this industry in China include the increasing healthcare expenditure, GDP growth, rising population base, and more favorable health insurance coverage.
Infectious diseases segment was identified as the largest revenue generating category in the application segment and is estimated to maintain its position due to the continual rise in the number of diseases estimated for the next few years.
The in vitro diagnostics industry comprises several local as well as global players. Some of the major players in this industry include Danaher Corporation, Affymetrix, Inc., Abbott Laboratories, Alere, Inc., Roche Diagnostics among others.
In order to gain a major share in the industry, the companies adopted both organic as well as inorganic growth strategies. The key strategies undertaken by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. For instance,in October 2015, Cepheid announced the launch of its newly developed, FDA approved test ‘Xpert TV’, an in-vitro diagnostic test for the accurate identification of Trichomoniasis in female patients.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Asia Pacific In Vitro Diagnostics Market - Industry Summary and Key Buying Criteria, 2013 - 2024
CHAPTER 3. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET: INDUSTRY OUTLOOK
3.1. Market segmentation
3.2. Market size and growth prospects, 2013-2024
3.3. Asia Pacific In vitro diagnostics Market: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing number of lifestyle diseases
3.3.1.2. Rising awareness of customized medicines
3.3.1.3. Increasing growth in geriatric population
3.3.2. Market restraint analysis
3.3.2.1. Reimbursement issues
3.3.2.2. Strict regulatory policies
3.4. In Vitro Diagnostics Market: Industry trend analysis
3.5. In Vitro Diagnostics Market:PESTEL Analysis
3.6. In Vitro Diagnostics Market Industry analysis - Porter's Five Forces Model
3.7. In Vitro Diagnostics market: Company Market Share Analysis (%), 2015
3.8. Key opportunities prioritized
CHAPTER 4. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET PRODUCT OUTLOOK
4.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Product, 2016 & 2024
4.2. Reagents and kits
4.2.1. Reagents and kits in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
4.3. Instruments
4.3.1. Instruments in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
4.4. Services
4.4.1. Services in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 5. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET TECHNOLOGY OUTLOOK
5.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Technology, 2016 & 2024
5.2. Clinical Chemistry
5.2.1. Clinical chemistryin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.3. Immunoassays
5.3.1. Immunoassays in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.4. Hematology
5.4.1. Hematologyin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.5. Coagulation
5.5.1. Coagulation in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.6. Microbiology
5.6.1. Microbiology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.7. Molecular Diagnostics
5.7.1. Molecular Diagnostics in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.8. Others
5.8.1. Otherin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 6. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET APPLICATION OUTLOOK
6.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Application, 2016 & 2024
6.2. Diabetes
6.2.1. Diabetes in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.3. Infectious Diseases
6.3.1. Infectious Diseases in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.4. Oncology
6.4.1. Oncology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.5. Nephrology
6.5.1. Nephrology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.6. Cardiology
6.6.1. Cardiology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.7. Autoimmune diseases
6.7.1. Autoimmune diseases in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.8. Drug Testing
6.8.1. Drug testingin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.9. Others
6.9.1. Otherin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 7. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET END-USER OUTLOOK
7.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by End-User, 2016 & 2024
7.2. Hospitals
7.2.1. Drug testingin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
7.3. Laboratories
7.3.1. Laboratories in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
7.4. Homecare Diagnostics
7.4.1. Homecare Diagnosticsin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
7.5. Others
7.5.1. Other in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 8. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKETREGIONAL OUTLOOK
8.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Country, 2016 & 2024
8.1.1. China
8.1.1.1. China in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
8.1.1.2. China invitro diagnostics market, by technology, 2013 - 2024 (USD Million)
8.1.1.3. China in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
8.1.1.4. China in vitro diagnostic market, by end-user, 2013-2024 (USD Million)
8.1.2. India
8.1.2.1. India in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
8.1.2.2. India in vitro diagnostics market, by technology, 2013 - 2024 (USD Million)
8.1.2.3. India in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
8.1.2.4. India in vitro diagnostic market, by end-user, 2013 - 2024 (USD Million)
8.1.3. Japan
8.1.3.1. Japan in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
8.1.3.2. Japan in vitro diagnostics market, by technology, 2013 - 2024 (USD Million)
8.1.3.3. Japan in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
8.1.3.4. Japan in vitro diagnostic market, by end-user, 2013 - 2024 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Becton, Dickinson and Company
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. bioMerieux, Inc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Abbott Laboratories
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. Alere, Inc.
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Hologic,Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. Cepheid, Inc.
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Roche Diagnostics
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Siemens Healthcare
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Strategic Initiatives
9.9. Bio-Rad Laboratories, Inc.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiative
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Asia Pacific In Vitro Diagnostics Market - Industry Summary and Key Buying Criteria, 2013 - 2024
CHAPTER 3. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET: INDUSTRY OUTLOOK
3.1. Market segmentation
3.2. Market size and growth prospects, 2013-2024
3.3. Asia Pacific In vitro diagnostics Market: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing number of lifestyle diseases
3.3.1.2. Rising awareness of customized medicines
3.3.1.3. Increasing growth in geriatric population
3.3.2. Market restraint analysis
3.3.2.1. Reimbursement issues
3.3.2.2. Strict regulatory policies
3.4. In Vitro Diagnostics Market: Industry trend analysis
3.5. In Vitro Diagnostics Market:PESTEL Analysis
3.6. In Vitro Diagnostics Market Industry analysis - Porter's Five Forces Model
3.7. In Vitro Diagnostics market: Company Market Share Analysis (%), 2015
3.8. Key opportunities prioritized
CHAPTER 4. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET PRODUCT OUTLOOK
4.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Product, 2016 & 2024
4.2. Reagents and kits
4.2.1. Reagents and kits in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
4.3. Instruments
4.3.1. Instruments in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
4.4. Services
4.4.1. Services in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 5. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET TECHNOLOGY OUTLOOK
5.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Technology, 2016 & 2024
5.2. Clinical Chemistry
5.2.1. Clinical chemistryin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.3. Immunoassays
5.3.1. Immunoassays in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.4. Hematology
5.4.1. Hematologyin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.5. Coagulation
5.5.1. Coagulation in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.6. Microbiology
5.6.1. Microbiology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.7. Molecular Diagnostics
5.7.1. Molecular Diagnostics in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
5.8. Others
5.8.1. Otherin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 6. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET APPLICATION OUTLOOK
6.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Application, 2016 & 2024
6.2. Diabetes
6.2.1. Diabetes in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.3. Infectious Diseases
6.3.1. Infectious Diseases in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.4. Oncology
6.4.1. Oncology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.5. Nephrology
6.5.1. Nephrology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.6. Cardiology
6.6.1. Cardiology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.7. Autoimmune diseases
6.7.1. Autoimmune diseases in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.8. Drug Testing
6.8.1. Drug testingin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
6.9. Others
6.9.1. Otherin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 7. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET END-USER OUTLOOK
7.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by End-User, 2016 & 2024
7.2. Hospitals
7.2.1. Drug testingin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
7.3. Laboratories
7.3.1. Laboratories in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
7.4. Homecare Diagnostics
7.4.1. Homecare Diagnosticsin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
7.5. Others
7.5.1. Other in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
CHAPTER 8. ASIA PACIFIC IN VITRO DIAGNOSTICS MARKETREGIONAL OUTLOOK
8.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Country, 2016 & 2024
8.1.1. China
8.1.1.1. China in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
8.1.1.2. China invitro diagnostics market, by technology, 2013 - 2024 (USD Million)
8.1.1.3. China in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
8.1.1.4. China in vitro diagnostic market, by end-user, 2013-2024 (USD Million)
8.1.2. India
8.1.2.1. India in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
8.1.2.2. India in vitro diagnostics market, by technology, 2013 - 2024 (USD Million)
8.1.2.3. India in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
8.1.2.4. India in vitro diagnostic market, by end-user, 2013 - 2024 (USD Million)
8.1.3. Japan
8.1.3.1. Japan in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
8.1.3.2. Japan in vitro diagnostics market, by technology, 2013 - 2024 (USD Million)
8.1.3.3. Japan in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
8.1.3.4. Japan in vitro diagnostic market, by end-user, 2013 - 2024 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Becton, Dickinson and Company
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. bioMerieux, Inc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Abbott Laboratories
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. Alere, Inc.
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Hologic,Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. Cepheid, Inc.
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Roche Diagnostics
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Siemens Healthcare
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Strategic Initiatives
9.9. Bio-Rad Laboratories, Inc.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiative
LIST OF TABLES
1. Asia Pacific IVD - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. Asia Pacific IVD market revenue, by product, 2013 - 2024 (USD Million)
3. Asia Pacific IVD market revenue, by technology, 2013 - 2024 (USD Million)
4. Asia Pacific IVD market revenue, by application, 2013 - 2024 (USD Million)
5. Asia Pacific IVD market revenue, by end-user, 2013 - 2024 (USD Million)
6. Asia Pacific IVD market, by region, 2013 - 2024 (USD Million)
7. Asia Pacific IVD- Key Market Driver Analysis
8. Asia Pacific IVD- Key Market Restraint Analysis
9. Asia Pacific IVD market revenue, 2013 - 2024 (USD Million)
10. China IVD market revenue, by product, 2013 - 2024 (USD Million)
11. China IVD market revenue, by technology, 2013 - 2024 (USD Million)
12. China IVD market revenue, by application, 2013 - 2024 (USD Million)
13. China IVD market revenue, by end-user, 2013 - 2024 (USD Million)
14. India IVD market revenue, by product, 2013 - 2024 (USD Million)
15. India IVD market revenue, by technology, 2013 - 2024 (USD Million)
16. India IVD market revenue, by application, 2013 - 2024 (USD Million)
17. India IVD market revenue, by end-user, 2013 - 2024 (USD Million)
18. Japan IVD market revenue, by product, 2013 - 2024 (USD Million)
19. Japan IVD market revenue, by technology, 2013 - 2024 (USD Million)
20. Japan IVD market revenue, by application, 2013 - 2024 (USD Million)
21. Japan IVD market revenue, by end-user, 2013 - 2024 (USD Million)
1. Asia Pacific IVD - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. Asia Pacific IVD market revenue, by product, 2013 - 2024 (USD Million)
3. Asia Pacific IVD market revenue, by technology, 2013 - 2024 (USD Million)
4. Asia Pacific IVD market revenue, by application, 2013 - 2024 (USD Million)
5. Asia Pacific IVD market revenue, by end-user, 2013 - 2024 (USD Million)
6. Asia Pacific IVD market, by region, 2013 - 2024 (USD Million)
7. Asia Pacific IVD- Key Market Driver Analysis
8. Asia Pacific IVD- Key Market Restraint Analysis
9. Asia Pacific IVD market revenue, 2013 - 2024 (USD Million)
10. China IVD market revenue, by product, 2013 - 2024 (USD Million)
11. China IVD market revenue, by technology, 2013 - 2024 (USD Million)
12. China IVD market revenue, by application, 2013 - 2024 (USD Million)
13. China IVD market revenue, by end-user, 2013 - 2024 (USD Million)
14. India IVD market revenue, by product, 2013 - 2024 (USD Million)
15. India IVD market revenue, by technology, 2013 - 2024 (USD Million)
16. India IVD market revenue, by application, 2013 - 2024 (USD Million)
17. India IVD market revenue, by end-user, 2013 - 2024 (USD Million)
18. Japan IVD market revenue, by product, 2013 - 2024 (USD Million)
19. Japan IVD market revenue, by technology, 2013 - 2024 (USD Million)
20. Japan IVD market revenue, by application, 2013 - 2024 (USD Million)
21. Japan IVD market revenue, by end-user, 2013 - 2024 (USD Million)
